Source: Eur Respir J 2011; 37: 393
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Martínez R., Menéndez R., Reyes S., Polverino E., Cillóniz C., Martínez A., Esquinas C., Filella X., Ramírez P., Torres A.. Factors associated with inflammatory cytokine patterns in community-acquired pneumonia. Eur Respir J 2011; 37: 393

Member's Comments

No comment yet.

Related content which might interest you: Systemic cytokine response in patients with community-acquired pneumonia Source: Eur Respir J 2011; 37: 1431-1438 Year: 2011 Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002 Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia Source: Eur Respir J 2013; 41: 1378-1385 Year: 2013 Cytokine responses, microbial etiology and short-term outcome in community-acquired pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Enhanced PMN response in chronic bronchitis and community-acquired pneumonia Source: Eur Respir J 2004; 24 : 772-778 Year: 2004 Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Serum levels of IL-6 in severe community-acquired pneumonia Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 Levels of IL-8 and IL-10 in the serum of blood of patients with nosocomial pneumonia at the abdominal sepsis Source: Eur Respir J 2005; 26: Suppl. 49, 189s Year: 2005 Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Effects of systemic steroids in patients with severe community-acquired pneumonia Source: Eur Respir J 2007; 30: 951-956 Year: 2007 Cytokines production in nosocomial pneumonia with various etiological Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005 Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Macrophage activation in exacerbated COPD with and without community-acquired pneumonia Source: Eur Respir J 2010; 36: 285 Year: 2010 Affecting factors of mortality in severe community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Corticosteroids in severe pneumonia Source: Eur Respir J 2008; 32: 259-264 Year: 2008 Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Age-depended levels of IL-2, IL-4 in children with community acquired pneumonia and wheezing Source: International Congress 2015 – Respiratory infections in children Year: 2015 Influence of antibiotic pre-treatment on inflammatory markers in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011